Title

Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye for Amblyopia in Children 3 to <7 Years Old
A Randomized Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye As Prescribed Treatments for Amblyopia in Children 3 to <7 Years Old
  • Phase

    Phase 3
  • Study Type

    Interventional
  • Intervention/Treatment

    atropine ...
  • Study Participants

    240
The purpose of the study is:

To compare the effectiveness and safety of weekend atropine augmented with a plano lens for the sound eye versus weekend atropine alone for moderate amblyopia (20/40 to 20/100) in children 3 to less than 7 years old.
To provide data on the response of severe amblyopia (20/125 to 20/400) to atropine treatment with and without a plano lens.
Atropine is an effective treatment of moderate amblyopia. Reduction of the plus sphere for the sound eye is an accepted method of enhancing and possibly accelerating the treatment effect. Demonstrating additional value of the plano lens in terms of speed of improvement will shorten the treatment period, possibly improving child and parental compliance, leading to improved overall outcomes for patients with amblyopia. If the plano lens leads to greater improvement, then there will be less permanent visual impairment in patients with a history of amblyopia. It also is important to determine if the use of a plano lens in conjunction with atropine has a deleterious effect on the sound eye, and if yes, how often this occurs.

Little is known about the pharmacologic treatment of severe amblyopia. This study will provide important prospectively determined outcome data at little additional expense.

In a study conducted by the Pediatric Eye Disease Investigator Group, A Randomized Trial Comparing Daily Atropine Versus Weekend Atropine for Moderate Amblyopia, the use of weekend atropine for moderate amblyopia was as effective as daily treatment. Intermittent atropine use (such as using it only on the weekends) has the theoretical potential benefit of the sound eye having some time each week during which cycloplegia is only partial. It is possible that allowing some loss of the cycloplegic effect over the course of each week may be safer for the sound eye.

The study has been designed as a simple trial that, other than the type of amblyopia therapy being determined through the randomization process, approximates standard clinical practice. The two treatment regimes for the 18 week primary treatment period are: 1) Atropine 1% once each weekend day in the sound eye and 2) Atropine 1% once each weekend day in the sound eye plus a plano lens for the sound eye.
Study Started
Feb 28
2005
Primary Completion
Oct 31
2007
Study Completion
Jan 31
2008
Results Posted
Aug 11
2011
Estimate
Last Update
Jul 19
2016
Estimate

Drug Atropine

Atropine 1% once each weekend day

Device Plano Lens

Plano lens for the sound eye

Atropine Active Comparator

Atropine 1% once each weekend day in the sound eye

Atropine plus plano Active Comparator

Atropine 1% once each weekend day in the sound eye plus a plano lens for the sound eye

Criteria

Inclusion Criteria:

Patients must be 3 to less than 7 years old with amblyopia associated with strabismus, anisometropia, or both.
Visual acuity in the amblyopic eye must be between 20/40 and 20/400 inclusive, visual acuity in the sound eye 20/40 or better and inter-eye acuity difference > 3 logMAR lines.
Spectacles, if needed, must be worn for at least 16 weeks or until visual acuity documented to be stable.

Exclusion Criteria:

Atropine treatment within 6 months of enrollment and other amblyopia treatment of any type (other than normal spectacle lenses) used within one month of enrollment
No myopia in amblyopic eye

Summary

Atropine-Moderate Amblyopia

Atropine Plus Plano-Moderate Amblyopia

Atropine-Severe Amblyopia

Atropine Plus Plano-Severe Amblyopia

All Events

Event Type Organ System Event Term Atropine-Moderate Amblyopia Atropine Plus Plano-Moderate Amblyopia Atropine-Severe Amblyopia Atropine Plus Plano-Severe Amblyopia

Visual Acuity Mean Score in the Amblyopic Eye

Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in an Snellen equivalent acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis. 20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst

Atropine-Moderate Amblyopia

0.23
logMAR units (Mean)
Standard Deviation: 0.16

Atropine Plus Plano-Moderate Amblyopia

0.22
logMAR units (Mean)
Standard Deviation: 0.20

Atropine-Severe Amblyopia

0.54
logMAR units (Mean)
Standard Deviation: 0.26

Atropine Plus Plano-Severe Amblyopia

0.5
logMAR units (Mean)
Standard Deviation: 0.38

Visual Acuity Distribution in the Amblyopic Eye

Visual acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at 18 weeks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This visual acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis. 20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst

Atropine-Moderate Amblyopia

20/100

2.0
Participants

20/125

20/160

20/16 (better)

1.0
Participants

20/20

11.0
Participants

20/200

20/25

12.0
Participants

20/250

20/32

28.0
Participants

20/320

20/40

18.0
Participants

20/400 (worse)

20/50

6.0
Participants

20/63

4.0
Participants

20/80

2.0
Participants

Atropine Plus Plano-Moderate Amblyopia

20/100

1.0
Participants

20/125

1.0
Participants

20/160

1.0
Participants

20/16 (better)

4.0
Participants

20/20

12.0
Participants

20/200

20/25

19.0
Participants

20/250

20/32

24.0
Participants

20/320

20/40

9.0
Participants

20/400 (worse)

20/50

7.0
Participants

20/63

6.0
Participants

20/80

4.0
Participants

Atropine-Severe Amblyopia

20/100

1.0
Participants

20/125

4.0
Participants

20/160

2.0
Participants

20/16 (better)

20/20

1.0
Participants

20/200

20/25

20/250

1.0
Participants

20/32

1.0
Participants

20/320

20/40

3.0
Participants

20/400 (worse)

20/50

5.0
Participants

20/63

5.0
Participants

20/80

1.0
Participants

Atropine Plus Plano-Severe Amblyopia

20/100

2.0
Participants

20/125

4.0
Participants

20/160

1.0
Participants

20/16 (better)

2.0
Participants

20/20

1.0
Participants

20/200

20/25

1.0
Participants

20/250

2.0
Participants

20/32

8.0
Participants

20/320

1.0
Participants

20/40

20/400 (worse)

1.0
Participants

20/50

4.0
Participants

20/63

2.0
Participants

20/80

2.0
Participants

Mean Change in Visual Acuity in the Amblyopic Eye

Acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. The score is converted to logMAR (log of min angle of resolution) for statistical analysis, and a difference between the scores is calculated. A positive difference indicates acuity was better at 18wks than at baseline; a negative difference indicates acuity was worse at 18wks than at baseline.

Atropine-Moderate Amblyopia

2.4
logMAR units (Mean)
Standard Deviation: 1.4

Atropine Plus Plano-Moderate Amblyopia

2.8
logMAR units (Mean)
Standard Deviation: 1.8

Atropine-Severe Amblyopia

4.5
logMAR units (Mean)
Standard Deviation: 3.1

Atropine Plus Plano-Severe Amblyopia

5.1
logMAR units (Mean)
Standard Deviation: 3.7

Distribution of Change in Visual Acuity in the Amblyopic Eye

Acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. The score is converted to logMAR (log of min angle of resolution) for statistical analysis, and a difference between the scores is calculated. A positive difference indicates acuity was better at 18wks than at baseline; a negative difference indicates acuity was worse at 18wks than at baseline.

Atropine-Moderate Amblyopia

0

4.0
Participants

-1

2.0
Participants

+1

18.0
Participants

-2

+2

18.0
Participants

+3

22.0
Participants

-3 (worse)

+4

17.0
Participants

>= +5 (better)

3.0
Participants

Atropine Plus Plano-Moderate Amblyopia

0

5.0
Participants

-1

2.0
Participants

+1

11.0
Participants

-2

+2

19.0
Participants

+3

18.0
Participants

-3 (worse)

1.0
Participants

+4

18.0
Participants

>= +5 (better)

14.0
Participants

Atropine-Severe Amblyopia

0

2.0
Participants

-1

+1

2.0
Participants

-2

+2

3.0
Participants

+3

3.0
Participants

-3 (worse)

+4

4.0
Participants

>= +5 (better)

3.0
Participants

Atropine Plus Plano-Severe Amblyopia

0

2.0
Participants

-1

1.0
Participants

+1

3.0
Participants

-2

1.0
Participants

+2

1.0
Participants

+3

2.0
Participants

-3 (worse)

+4

3.0
Participants

>= +5 (better)

3.0
Participants

Randot Preschool Stereoacuity at 18 Weeks- Participants With All Causes of Amblyopia

The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.

Atropine Plus Plano-Moderate Amblyopia

100 arcsec

10.0
Participants

200 arcsec

6.0
Participants

400 arcsec

12.0
Participants

40 arcsec (best)

1.0
Participants

60 arcsec

1.0
Participants

800 arcsec

10.0
Participants

>800 arcsec (worst)

41.0
Participants

Failed black & white shape identification pretest

4.0
Participants

Not done

3.0
Participants

Atropine-Severe Amblyopia

Atropine Plus Plano-Severe Amblyopia

Atropine-Moderate Amblyopia

100 arcsec

4.0
Participants

200 arcsec

10.0
Participants

400 arcsec

11.0
Participants

40 arcsec (best)

2.0
Participants

60 arcsec

5.0
Participants

800 arcsec

7.0
Participants

>800 arcsec (worst)

40.0
Participants

Failed black & white shape identification pretest

3.0
Participants

Not done

2.0
Participants

Randot Preschool Stereoacuity at 18 Weeks- Anisometropic Participants Only

The Randot Preschool Stereotest measures stereopsis from 800 to 40 seconds of arc on patients as young as 2 years of age. This Stereotest is designed as a matching game in which the patient matches pictures in a test booklet wearing special glasses. A subject can fail the pretest (not see any pictures) or can score >800 (the worst), 800, 400, 200, 100, 60, or 40 (the best) seconds of arc. If two shapes are identified correctly the patient progresses to the next lower stereoacuity level. A failed test occurs when the patient cannot identify any shapes.

Atropine-Moderate Amblyopia

100 arcsec

3.0
Participants

200 arcsec

8.0
Participants

400 arcsec

5.0
Participants

40 arcsec (best)

2.0
Participants

60 arcsec

1.0
Participants

800 arcsec

2.0
Participants

>800 arcsec (worst)

7.0
Participants

Failed black & white shape identification pretest

Not done

1.0
Participants

Atropine Plus Plano-Moderate Amblyopia

100 arcsec

6.0
Participants

200 arcsec

3.0
Participants

400 arcsec

6.0
Participants

40 arcsec (best)

1.0
Participants

60 arcsec

1.0
Participants

800 arcsec

3.0
Participants

>800 arcsec (worst)

9.0
Participants

Failed black & white shape identification pretest

Not done

1.0
Participants

Atropine-Severe Amblyopia

Atropine Plus Plano-Severe Amblyopia

Mean Change in Visual Acuity in the Sound Eye

Acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. The score is converted to logMAR (log of min angle of resolution) for statistical analysis, and a difference between the scores is calculated. A positive difference indicates acuity was better at 18wks than at baseline; a negative difference indicates acuity was worse at 18wks than at baseline.

Atropine-Moderate Amblyopia

0.4
logMAR units (Mean)
Standard Deviation: 0.9

Atropine Plus Plano-Moderate Amblyopia

Atropine-Severe Amblyopia

0.1
logMAR units (Mean)
Standard Deviation: 0.12

Atropine Plus Plano-Severe Amblyopia

0.15
logMAR units (Mean)
Standard Deviation: 0.15

Distribution of Change in Visual Acuity in the Sound Eye

Acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. The score is converted to logMAR (log of min angle of resolution) for statistical analysis, and a difference between the scores is calculated. A positive difference indicates acuity was better at 18wks than at baseline; a negative difference indicates acuity was worse at 18wks than at baseline.

Atropine-Moderate Amblyopia

0

49.0
Participants

-1

3.0
Participants

+1

24.0
Participants

-2

+2

6.0
Participants

-3

+3 (better)

1.0
Participants

-4 (worse)

1.0
Participants

Atropine Plus Plano-Moderate Amblyopia

0

50.0
Participants

-1

12.0
Participants

+1

17.0
Participants

-2

3.0
Participants

+2

4.0
Participants

-3

1.0
Participants

+3 (better)

-4 (worse)

1.0
Participants

Atropine-Severe Amblyopia

0

11.0
Participants

-1

+1

9.0
Participants

-2

1.0
Participants

+2

3.0
Participants

-3

+3 (better)

-4 (worse)

Atropine Plus Plano-Severe Amblyopia

0

13.0
Participants

-1

2.0
Participants

+1

12.0
Participants

-2

4.0
Participants

+2

-3

+3 (better)

-4 (worse)

Visual Acuity Distribution in the Sound Eye

Acuity is measured in each eye using the Amblyopia Treatment Study (ATS) visual acuity testing protocol at baseline and at 18 wks resulting in a Snellen acuity score that can range from 20/16 to 20/800. This acuity score is converted to logMAR (log of min angle of resolution) for statistical analysis. 20/16=-0.1 logMAR; best 20/20=0.0 logMAR; 20/25=0.1; 20/32=0.2; 20/40=0.3; 20/50=0.4; 20/63=0.5; 20/80=0.6; 20/100=0.7; 20/125=0.8; 20/160=0.9; 20/200=1.0; 20/250=1.1; 20/320=1.2; 20/400=1.3; 20/500=1.4; 20/640=1.5; 20/800=1.6; worst

Atropine-Moderate Amblyopia

20/16 (better)

21.0
Participants

20/20

36.0
Participants

20/25

14.0
Participants

20/32

10.0
Participants

20/40

2.0
Participants

20/50

20/63 (worse)

1.0
Participants

Atropine Plus Plano-Moderate Amblyopia

20/16 (better)

15.0
Participants

20/20

28.0
Participants

20/25

22.0
Participants

20/32

16.0
Participants

20/40

3.0
Participants

20/50

3.0
Participants

20/63 (worse)

1.0
Participants

Atropine-Severe Amblyopia

20/16 (better)

2.0
Participants

20/20

6.0
Participants

20/25

8.0
Participants

20/32

6.0
Participants

20/40

1.0
Participants

20/50

1.0
Participants

20/63 (worse)

Atropine Plus Plano-Severe Amblyopia

20/16 (better)

2.0
Participants

20/20

7.0
Participants

20/25

7.0
Participants

20/32

7.0
Participants

20/40

4.0
Participants

20/50

3.0
Participants

20/63 (worse)

1.0
Participants

Total

240
Participants

Age, Continuous

5.0
years (Mean)
Standard Deviation: 1.1

Distance Visual Acuity in Amblyopic Eye

0.61
log of min angle of resolution (logMAR) (Mean)
Standard Deviation: 0.27

Distance Visual Acuity in Sound Eye

.09
log of min angle of resolution (logMAR) (Mean)
Standard Deviation: .11

Intereye Acuity Difference

5.2
logMAR lines (Mean)
Standard Deviation: 2.4

Refractive Error in Amblyopic Eye (spherical equivalent/diopters)

5.05
diopters (Mean)
Standard Deviation: 1.72

Refractive Error in Sound Eye (spherical equivalent/diopters)

3.63
diopters (Mean)
Standard Deviation: 1.79

Age, Categorical

Cause of Amblyopia

Distance Visual Acuity in Amblyopic Eye

Distance Visual Acuity in Sound Eye

Prior Treatment for Amblyopia at Enrollment

Race/Ethnicity, Customized

Refractive Error in Amblyopic Eye (spherical equivalent/diopters)

Refractive Error in Sound Eye (spherical equivalent/diopters)

Region of Enrollment

Sex: Female, Male

Overall Study

Atropine-Moderate Amblyopia

Atropine Plus Plano-Moderate Amblyopia

Atropine-Severe Amblyopia

Atropine Plus Plano-Severe Amblyopia